Strategic BC Salmon Health Initiative: Inventory and Assessment of Health Risk of Microbes in BC’s Pacific Salmon

The role of infectious disease in declining productivity of wild salmon in BC is poorly understood. We will combine novel genomic technologies with traditional fish health methodologies and more broadly identify the microbe exposure of BC salmon. By doing so, we can examine their evolutionary relationships and their epidemiological distribution patterns over time and space […]

Read More
Clinical development of avocado-derived lipids as modulators of fatty acid oxidation for the treatment and management of obesity and diabetes

Obesity and diabetes are a significant global burden and there is an immediate need for novel treatments and management strategies. Our lab has shown that an avocadoderived lipid is a potent inhibitor of fatty acid oxidation (i.e., the cellular breakdown of fat for energy) which reduces mouse weight gain without toxicity. Inhibition of fatty acid […]

Read More
Expanding the capabilities of a neurosurgery software platform to provide clinical solutions for advanced spinal cord imaging and intra-operative guidance

Pathologic changes that occur in the cervical spinal cord as a result of injury and disease are not well characterized with current clinical imaging techniques. Synaptive Medical has recently developed a suite of innovative medical imaging products focused on the brain and image-guided neurosurgery. They are interested in investigating the potential application of these technologies […]

Read More
Novel Biomarker Identification for Human Cytomegalovirus Disease in Transplant Patients

Organ transplants save patients with severe end stage organ failure but the need for subsequent lifelong immunosuppression can lead to a number of undesired consequences including the reactivation of viruses of donor or recipient origin. Human cytomegalovirus (HCMV) infection is the most common opportunistic infection in transplant patients and can lead to significant morbidity and […]

Read More
Design and validation of a novel peptide immunotherapeutic for the treatment of dog allergies

Adiga Life Sciences Inc. developed a novel immunotherapeutic platform in which small components (peptides) of allergen proteins are identified and administered in a regimen that causes immune cells to become non-responsive towards the allergens. In a phase II clinical trial, the cat allergy treatment developed by Adiga using this platform reduced allergic symptoms in allergic […]

Read More
Defining cell therapies using CNS tissue sources in living Parkinson’s Disease patients

There is a critical need for new therapies for Parkinson’s Disease (PD), a devastating neurodegenerative disease. Current therapies for PD treat disease symptoms, but do not provide a cure. The ability to generate patient brain-derived cells may rapidly advance development of personalized therapies for PD and other incurable neurological disorders. This study will use brain […]

Read More
Intracellular growth of Mycobacterium tuberculosis: prospects for drug discovery

The success of Mycobacterium tuberculosis (Mtb), the infectious agent of tuberculosis (TB), lies in its ability to primarily infect, reside, and multiply in the lungs of patients. Mtb infects white blood cells termed alveolar macrophages and hides from the host immune response as well as from many antibiotics used for treatment, creating additional challenges for […]

Read More
Circulating Tumor Cell (CTC) telomeric analysis in pre-treatment and post-treatment patients with prostatic adenocarcinoma; a look at prognostic variability and responsive elements

The intern will analyze blood samples of patients with high-risk prostate cancer. The cancer cells will be isolated from the blood sample and the genetic material will be stained and then imaged by a high-intensity-high-focus 3D microscope. Next, the telomeres (ends of genes) will be studied and compared. The point is to see the progression […]

Read More